EBMT 2019 | CART19-BE-01 trial: next-generation CAR T-cell therapy for CD19+ R/R leukemia and lymphoma

Valentín Ortiz-Maldonado

Valentín Ortiz-Maldonado, MD, of Hospital Clinic of Barcelona, Barcelona, Spain talks about the current status of the Phase I CART19-BE-01 pilot study (NCT03144583), which investigates the infusion of ARI-0002 cells in patients with relapsed/refractory CD19+ hematological malignancies. This video was recorded at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video